drugset / Trial / NCT07862114

A Study to Investigate the Effect of Omeprazole and Cyclosporine on Velzatinib in Healthy Participants

NCT07862114 ↗

Phase 1 Not yet recruiting 36 enrolled GlaxoSmithKline
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study will look at how two commonly used medicines, omeprazole and cyclosporine, influence the way the body absorbs, processes, and eliminates velzatinib in healthy volunteers.

Timeline

Start
2026-10-16
Primary completion
2027-01-12
Completion
2027-01-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide — —
Subject IDRX-42 Small molecule — —
Subject Omeprazole Other / unclassified — —